JP2025501214A5 - - Google Patents
Info
- Publication number
- JP2025501214A5 JP2025501214A5 JP2024539426A JP2024539426A JP2025501214A5 JP 2025501214 A5 JP2025501214 A5 JP 2025501214A5 JP 2024539426 A JP2024539426 A JP 2024539426A JP 2024539426 A JP2024539426 A JP 2024539426A JP 2025501214 A5 JP2025501214 A5 JP 2025501214A5
- Authority
- JP
- Japan
- Prior art keywords
- ipsc
- antigen
- domain
- seq
- cells
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163294618P | 2021-12-29 | 2021-12-29 | |
| US63/294,618 | 2021-12-29 | ||
| US202263350156P | 2022-06-08 | 2022-06-08 | |
| US63/350,156 | 2022-06-08 | ||
| PCT/US2022/082441 WO2023129937A1 (en) | 2021-12-29 | 2022-12-27 | Genetically engineered cells having anti-cd19 / anti-cd22 chimeric antigen receptors, and uses thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025501214A JP2025501214A (ja) | 2025-01-17 |
| JP2025501214A5 true JP2025501214A5 (https=) | 2026-01-13 |
Family
ID=85222536
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024539426A Pending JP2025501214A (ja) | 2021-12-29 | 2022-12-27 | 抗ｃｄ１９／抗ｃｄ２２キメラ抗原受容体を有する遺伝子操作細胞、およびその使用 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20250064934A1 (https=) |
| EP (1) | EP4456912A1 (https=) |
| JP (1) | JP2025501214A (https=) |
| AU (1) | AU2022423987A1 (https=) |
| CA (1) | CA3243966A1 (https=) |
| TW (1) | TW202342734A (https=) |
| WO (1) | WO2023129937A1 (https=) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20250090582A1 (en) * | 2022-06-08 | 2025-03-20 | Century Therapeutics, Inc. | Genetically engineered cells having anti-cd133 / anti-egfr chimeric antigen receptors, and uses thereof |
| AU2023375625A1 (en) * | 2022-11-10 | 2025-05-15 | Century Therapeutics, Inc. | Genetically engineered cells having anti-nectin4 chimeric antigen receptors, and uses thereof |
| WO2025207795A1 (en) * | 2024-03-26 | 2025-10-02 | Juno Therapeutics, Inc. | Genetically engineered cells having anti-cd33 / anti-cd123 chimeric antigen receptors, and uses thereof |
| WO2025207798A1 (en) * | 2024-03-26 | 2025-10-02 | Century Therapeutics, Inc. | Genetically engineered cells having anti-cd123 chimeric antigen receptors, and uses thereof |
| WO2025214438A1 (zh) * | 2024-04-10 | 2025-10-16 | 浙江纳米抗体技术中心有限公司 | 结合cd19和/或cd22的抗原结合分子及其用途 |
| CN121537531A (zh) * | 2026-01-16 | 2026-02-17 | 北京肿瘤医院(北京大学肿瘤医院) | 一种表达cd47-cd28共刺激转换受体的嵌合抗原受体及其应用 |
Family Cites Families (33)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9710809D0 (en) | 1997-05-23 | 1997-07-23 | Medical Res Council | Nucleic acid binding proteins |
| GB9710807D0 (en) | 1997-05-23 | 1997-07-23 | Medical Res Council | Nucleic acid binding proteins |
| US6140081A (en) | 1998-10-16 | 2000-10-31 | The Scripps Research Institute | Zinc finger binding domains for GNN |
| US6453242B1 (en) | 1999-01-12 | 2002-09-17 | Sangamo Biosciences, Inc. | Selection of sites for targeting by zinc finger proteins and methods of designing zinc finger proteins to bind to preselected sites |
| US6534261B1 (en) | 1999-01-12 | 2003-03-18 | Sangamo Biosciences, Inc. | Regulation of endogenous gene expression in cells using zinc finger proteins |
| JP2002060786A (ja) | 2000-08-23 | 2002-02-26 | Kao Corp | 硬質表面用殺菌防汚剤 |
| JP2005500061A (ja) | 2001-08-20 | 2005-01-06 | ザ スクリップス リサーチ インスティテュート | Ｃｎｎについての亜鉛フィンガー結合ドメイン |
| US7888121B2 (en) | 2003-08-08 | 2011-02-15 | Sangamo Biosciences, Inc. | Methods and compositions for targeted cleavage and recombination |
| US7972854B2 (en) | 2004-02-05 | 2011-07-05 | Sangamo Biosciences, Inc. | Methods and compositions for targeted cleavage and recombination |
| US8846395B2 (en) | 2005-06-01 | 2014-09-30 | Wisconsin Alumni Research Foundation | Generation of mature myelomonocytic cells through expansion and differentiation of pluripotent stem cell-derived lin-CD34+CD43+CD45+progenitors |
| KR100902340B1 (ko) | 2007-08-02 | 2009-06-12 | 한국생명공학연구원 | Ｙｃ－１ 또는 ｉｌ－２１을 유효성분으로 포함하는자연살해세포 분화제 및 분화 방법 |
| EP3279314A1 (en) | 2008-06-04 | 2018-02-07 | Cellular Dynamics International, Inc. | Methods for the production of ips cells using non-viral approach |
| EP2336303B1 (en) | 2008-09-08 | 2015-07-15 | Riken | NKT CELL-DERIVED iPS CELLS AND NKT CELLS DERIVED THEREFROM |
| KR101720961B1 (ko) | 2009-02-27 | 2017-03-29 | 셀룰러 다이내믹스 인터내셔널, 인코포레이티드 | 다능성 세포의 분화 |
| WO2011072246A2 (en) | 2009-12-10 | 2011-06-16 | Regents Of The University Of Minnesota | Tal effector-mediated dna modification |
| CA2806858C (en) | 2010-08-04 | 2021-06-15 | Cellular Dynamics International, Inc. | Reprogramming immortalized b cells |
| CA2826386C (en) | 2011-02-08 | 2020-04-28 | FUJIFILM Cellular Dynamics, Inc. | Hematopoietic precursor cell production by programming |
| JP6715482B2 (ja) | 2014-07-18 | 2020-07-01 | 国立大学法人京都大学 | 多能性幹細胞から免疫細胞療法用ｔ細胞を誘導する方法 |
| US10947502B2 (en) | 2015-10-20 | 2021-03-16 | FUJIFILM Cellular Dynamics, Inc. | Methods for directed differentiation of pluripotent stem cells to immune cells |
| LT3444334T (lt) | 2016-04-15 | 2021-12-10 | Kyoto University | Antigenui specifinių cd8 teigiamų t ląstelių indikavimo būdas |
| US11525119B2 (en) | 2016-09-06 | 2022-12-13 | The Children's Medical Center Corporation | Immune cells derived from induced pluripotent stem cell |
| CN109996868A (zh) | 2016-09-23 | 2019-07-09 | 弗雷德哈钦森癌症研究中心 | 特异性用于次要组织相容性(h)抗原ha-1的tcr及其用途 |
| CA3070998A1 (en) | 2017-07-25 | 2019-01-31 | Board Of Regents, The University Of Texas System | Enhanced chimeric antigen receptors and use thereof |
| WO2019060695A1 (en) | 2017-09-22 | 2019-03-28 | Kite Pharma, Inc. | CHIMERIC POLYPEPTIDES AND USES THEREOF |
| EP4269560A3 (en) | 2017-10-03 | 2024-01-17 | Precision Biosciences, Inc. | Modified epidermal growth factor receptor peptides for use in genetically-modified cells |
| CA3091158A1 (en) | 2018-02-14 | 2019-08-22 | Sunnybrook Research Institute | Method for generating cells of the t cell lineage |
| JP7546554B2 (ja) * | 2018-09-26 | 2024-09-06 | レンティジェン・テクノロジー・インコーポレイテッド | 抗ｃｄ１９／ｃｄ２２免疫療法によりがんを処置するための組成物および方法 |
| EP4041759A4 (en) * | 2019-10-07 | 2023-12-20 | Fate Therapeutics, Inc. | IMPROVED CHIMERIC ANTIGEN RECEPTOR FOR IMMUNE EFFECTOR CELL CULTURE AND USE THEREOF |
| WO2021092252A1 (en) * | 2019-11-05 | 2021-05-14 | Forman Stephen J | Generation of chimeric antigen receptor modified t cells from stem cells and therapeutic uses thereof |
| EP4065157A1 (en) * | 2019-11-26 | 2022-10-05 | Novartis AG | Cd19 and cd22 chimeric antigen receptors and uses thereof |
| CA3171906A1 (en) * | 2020-03-16 | 2021-09-23 | University Of Southern California | Novel antigen binding domains and synthetic antigen receptors incorporating the same |
| BR112022025806A2 (pt) * | 2020-06-19 | 2023-03-07 | Fate Therapeutics Inc | Combinação de tipos de células efetoras derivadas de ipsc para uso em imunoterapia |
| AR124414A1 (es) * | 2020-12-18 | 2023-03-22 | Century Therapeutics Inc | Sistema de receptor de antígeno quimérico con especificidad de receptor adaptable |
-
2022
- 2022-12-27 AU AU2022423987A patent/AU2022423987A1/en active Pending
- 2022-12-27 WO PCT/US2022/082441 patent/WO2023129937A1/en not_active Ceased
- 2022-12-27 CA CA3243966A patent/CA3243966A1/en active Pending
- 2022-12-27 US US18/722,839 patent/US20250064934A1/en active Pending
- 2022-12-27 JP JP2024539426A patent/JP2025501214A/ja active Pending
- 2022-12-27 EP EP22856960.4A patent/EP4456912A1/en active Pending
- 2022-12-29 TW TW111150534A patent/TW202342734A/zh unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2025501214A5 (https=) | ||
| JP7745032B2 (ja) | 一本鎖および多鎖キメラポリペプチドならびにその使用方法 | |
| JP7781243B2 (ja) | ガイダンス及びナビゲーションコントロール蛋白質並びにその生産及び使用方法 | |
| JP2024519515A5 (https=) | ||
| JP2023553419A5 (https=) | ||
| JP7091447B2 (ja) | 新型なｓｃＦｖアミノ酸配列、それを含むキメラ抗原受容体、およびその使用 | |
| JP6499245B2 (ja) | 形質導入Ｔ細胞選択のためのトランケート上皮増殖因子レセプタ（ＥＧＦＲｔ） | |
| US12060394B2 (en) | Nucleic acid constructs for co-expression of chimeric antigen receptor and transcription factor, cells containing and therapeutic use thereof | |
| CN112469829B (zh) | 包含抗gpc3单链抗体的car | |
| CN107660213B (zh) | 人源化抗MUCl＊抗体 | |
| JP2024513906A5 (https=) | ||
| CN112955465A (zh) | 抗tcr抗体分子及其用途 | |
| KR20210019993A (ko) | Τ 세포 수용체 및 이를 발현하는 조작된 세포 | |
| US11957717B2 (en) | Anti-human MSLN antibody and MSLN-targeting immune effector cell | |
| JP2023515211A5 (https=) | ||
| EP4400516A1 (en) | Bispecific or-gate chimeric antigen receptor responsive to cd19 and cd20 | |
| CN116234829A (zh) | 抗tcr抗体分子及其用途 | |
| JP2022553818A (ja) | 二重標的キメラ抗原レセプターｔ細胞療法のためのプロテアーゼスイッチ | |
| KR102316091B1 (ko) | Bcma를 표적으로 하는 키메라 항원 수용체 및 이의 용도 | |
| CN117597359A (zh) | 与tcr结合的多功能分子及其用途 | |
| TW201905198A (zh) | 用於降低嵌合刻痕受體之免疫原性的方法與組合物 | |
| RU99101121A (ru) | Полипептиды, способные к образованию антигенсвязывающих структур со специфичностью к резус-d-антигенам, днк, кодирующая их, способы их получения и применение | |
| JP2023515747A (ja) | 免疫調節分子を発現する細胞および免疫調節分子を発現するための系 | |
| CN121487747A (zh) | 使用与tcr结合的分子的组合疗法 | |
| EP4061385A1 (en) | A method for redesign and expansion of nk92 cells for use in immunotherapy |